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ABSTRACT 
Objective: The objective of the present study is to explore the vipaka of an extra-pharmacopoeia drug Bridelia stipularis
Methods: 12 Wistar strain albino rats were selected and divided into 2 groups; Group A-Control, Group B-Test group. Each rat was kept in separate 
metabolic cages provided with a constant amount of water and food per day. Assessment of vipaka was done based on the consumption of food, 
consumption of water, the quantity of faecal matter, urine output, and quantity of water content of expelled faecal matter per day. Assessment of 
Vipaka was done on the basis of consumption of food; consumption of water; the quantity of faecal matter, urine output and quantity water content 
of expelled faecal matter per day. Assessment of Vipaka was done on the basis of consumption of food; consumption of water; the quantity of faecal 
matter, urine output and quantity water content of expelled faecal matter per day. 
 (L.) Blume belongs to the 
Euphorbiaceae family. 
Results: Absolute values of Group B or test group exhibited significant increase in water consumption (p<0.01), wet faecal matter (p<0.05), dry faecal 
matter (p<0.001), and food conversion ratio (p<0.05), and non-significant increase in food consumption, urine output, faecal water, and body weight. 
Conclusion: Based on the preliminary analysis it may be concluded that the drug Bridelia stipularis (L.) Blume possess Madhura vipaka (Sweet 
metabolic transformation). 
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INTRODUCTION 
Ayurvedic science has got an immense database of herbal drugs. 
It is becoming increasingly popular worldwide with many 
chronic conditions responding to it well. On the other hand, the 
scarcity of popular herbs makes a hindrance to meet this 
demand. Here arises the need for exploring extra-
pharmacopoeial drugs. Bridelia stipularis (L.) Blume is one of the 
extra-pharmacopoeial drugs having wide uses. It is a large 
woody evergreen climber or straggling shrub belonging to the 
family Euphorbiaceae and is distributed in South-east Asia like 
the central and eastern parts of Bangladesh, India, and Myanmar 
(Kritikar K R et al.,
Ayurvedic pharmacological properties or rasapancakas are the 
fundamental principles of Ayurveda based on which drug actions 
can be explained. So, for utilizing a new drug in Ayurveda based on 
Ayurvedic fundamental principles, the knowledge of Rasa (Taste), 
Guna (Property), V
1975). Different parts of this plant are 
applicable for various treatments. Bark decoction is given to 
children for cough, fever, and asthma and as a gargle for sores in 
the mouth. Fresh tender leaves are used for the treatment of 
jaundice and anemia due to pregnancy [1]. Root extract along 
with the combination of other plant is used to treat herpes [2]. 
The decoction of wood is used in the treatment of Malaria 
disease [3]. 
ī
MATERIALS AND METHODS 
rya (Active potency), Vipaka (Metabolism) of the 
drug is mandatory. Since the ayurvedic pharmacological properties 
of Bridelia stipularis not yet been explored, the present study was 
conducted to assess the vipaka of the drug. Vipaka can be defined as 
the outcome of the biotransformation of the rasa (taste) of a dravya 
through the action of jatharagni [4]. Acarya Caraka well explained 
the action of vipāka on dośa, dhatu, and mala [5]. On this footing, an 
experiment was carried out and assessment of vipāka was done 
based on the consumption of food, consumption of water, the 
quantity of faecal matter, urine output, and quantity of water 
content of expelled faecal matter per day. 
Plant material 
Bridelia stipularis (L.) Blume was collected from Chelari, 
Malappuram district, Kerala and authenticated from CMPR (Centre 
for Medicinal Plant Research), Aryavaidyasala, Kottakkal, Kerala, 
India (specimen no. CMPR10961). 
Preparation of leaf decoction 
The decoction was made by the conventional method of kwātha 
preparation as per Śārngadhara Saṃhita by taking 16 times water 
and reduced to 1/8th
Animal 
. The kwātha sieved and filtered to remove all 
the drug particles and reduced in low flame with 15% of talc (IP 
grade) to get a uniform dried solid mass. Then it was powdered and 
stored in an airtight container. 
Wistar strain albino rats of either sex between 150–250g body 
weights were obtained from the animal house attached to the 
Department of Pharmacology, SDM Centre for Research in Ayurveda 
and Allied Sciences, Udupi, Karnataka, India following approval of 
synopsis on 29/05/2017 (Approval No: SDMCRA/IAEC/KT-DG-01). 
The animals were fed with normal rat diet and water ad libitum 
throughout the study period. They were acclimatized in the 
laboratory condition for two weeks before the study. The housing 
conditions: controlled lighting of 12:12h light and dark cycle, the 
temperature of 25 °C and relative humidity of about 50%. 
Study design 
Twelve rats were selected, which were separated into 2 groups. 
Each rat was kept in separate metabolic cages after proper labeling 
for identity. The rats were weighed and the group was named as 
Group A-Control group, Group B–Test group. Each rat from two 
groups was kept in separate cages provided with a constant amount 
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of water and food per day. To each rat 200 ml of water and 100g 
food were provided in the food hopper and bottle holder per day. 
After 24h the amount of left-over water and food was measured to 
obtain the quantity of water and food consumed per day, this was 
recorded for consecutive 5 d without administering the drug to the 
rats in both groups. On the sixth day onwards the test drug was 
administered at the dose of 200 mg/kg body weight to the test group 
and the same procedure was repeated for 10 more days. Quantity of 
stool and urine was measured every day. On every alternative day, 
the weight of each rat from all the groups was noted. The 
parameters recorded for each rat on a day were, food consumption, 
water ingestion, faecal output (wet fecal-immediate after collection 
and dry fecal-after keeping in hot air oven for 105 °C temperature 
for 4 h), faecal water (wet faecal weight-dry faecal weight), urine 
output and food conversion ratio [Food consumption (divided by) 
dry faecal weight per day] both in Absolute value and relative value. 
Statistical analysis 
All the values were expressed as MEAN±SEM (standard error of the 
mean) and the data were analyzed by the unpaired-test and paired-
test. A level of P<0.05 was considered statistically significant. The 




Table 1: Effect of Bridelia stipularis (L.) Blume on food consumption with data presented in terms of absolute value 
Group Food consumption in g/100 g body weight (absolute value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % change 
Control 18.14±0.79 15.23±0.60 -- 
Test drug 15.68±0.52 16.67±0.36 9.46↑ 
n=6, The expressions were calculated by taking mean±standard error to the mean p-value less than 0.05 was counted as significant in comparison to 
control 
 
Table 1 shows after administering the test drug, food intake in gm/d 
was increased by 9.46% in the test group when compared to the 
control group; however, that increased data were statistically not 
significant. 
 
Table 2: Effect of Bridelia stipularis (L.) blume on food consumption with data presented in terms of relative value 
Group Food consumption in g/100 g body weight (relative value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 7.06±0.28 6.30±0.17 -- 
Test drug 6.13±0.26 6.60±0.35 4.76↑ 
n=6, The expressions were calculated by taking mean±standard error to the mean p-value less than 0.05 was counted as significant in comparison to 
control 
 
Table 2 shows after administering the test drug, food intake in gm/d 
was increased by 4.76% in the test group when compared to the 
control group; however, that increased data were statistically not 
significant. 
 
Table 3: Effect of Bridelia stipularis (L.) blume on water consumption with data presented in terms of absolute value 
Group Water consumption in ml/100 g body weight (absolute value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 31.80±0.96 21.58±0.91 -- 
Test drug 26.7±0.64 26.27±1.03** 21.73↑ 
n=6, the expressions were calculated by taking mean±standard error to the mean **p-value less than 0.01 was counted as highly significant in 
comparison to control 
 
Table 3 shows after the administration of the test drug, water intake 
in ml/d were increased by 21.73% in the test group when compared 
to the control group; the observed increase was statistically 
significant at the level of P<0.01. 
  
Table 4: Effect of Bridelia stipularis (L.) blume on water consumption with data presented in terms of relative value 
Group Water intake in ml/100 g body weight (relative value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 12.46±0.31 8.63±0.53 -- 
Test drug 11.04±0.56 10.44±0.74 20.97↑ 
n=6, The expressions were calculated by taking mean±standard error to the mean p-value less than 0.05 was counted as significant in comparison to 
control 
 
Table 4 shows after the administration of the test drug, water intake 
in ml/d were increased by 20.97% in the test group when compared 
to the control group; however, that increased data were statistically 
not significant. 
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Table 5: Effect of Bridelia stipularis (L.) blume on urine output with data presented in terms of absolute value 
Group Urine output in ml/100 g body weight (absolute value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 6.68±0.52 4.22±0.46 -- 
Test drug 5.47±0.38 5.56±0.70 31.75↑ 
n=6, the expressions were calculated by taking mean±standard error to the mean p-value less than 0.05 was counted as significant in comparison to 
control 
 
Table 5 shows after the administration of the test drug urine output 
in ml/d were increased by 31.75% in the test group when compared 
to the control group; however, that increased data were statistically 
not significant. 
  
Table 6: Effect of Bridelia stipularis (L.) Blume on urine output with data presented in terms of relative value 
Group Urine output in ml/100 g body weight (relative value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 2.75±0.29 2.26±0.56 -- 
Test drug 2.26±0.20 2.19±0.28 3.09↓ 
n=6, The expressions were calculated by taking mean±standard error to the mean p-value less than 0.05 was counted as significant in comparison to 
control. 
 
Table 6 shows after the administration of the test drug urine output 
in ml/d were decreased by 31.75% in the test group when compared 
to the control group; however, decreased data were statistically not 
significant.
 
Table 7: Effect of Bridelia stipularis (L.) blume on the faecal matter (wet) with data presented in terms of absolute value 
Group Faecal matter (wet) in g/100 g body weight (absolute value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 7.47±0.33 7.09±0.54 -- 
Test drug 9.32±0.72 9.22±0.52* 30.04↑ 
n=6, The expressions were calculated by taking mean±standard error to the mean *p-value less than 0.05 was counted as significant in comparison 
to control 
 
Table 7 shows after the administration of the test drug wet faecal 
output in gm/d was a 30.04% increase in the test group compared to 
the control group. The increased data were statistically significant 
(‘P’ value less than 0.05). 
 
Table 8: Effect of Bridelia stipularis (L.) blume on the faecal matter (wet) with data presented in terms of relative value 
Group Faecal matter (wet) in g/100 g body weight (relative value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 3.48±0.18 3.3±0.11 -- 
Test drug 3.83±0.33 3.64±0.24 10.30↑ 
n=6, the expressions were calculated by taking mean±standard error to the mean p-value less than 0.05 was counted as significant in comparison to 
control. 
 
Table 8 shows after administration of the test drug wet faecal output 
in gm/d was a 10.30% increase in the test group compared to the 
control group; however, that increased data were statistically non-
significant.
 
Table 9: Effect of Bridelia stipularis (L.) blume on the faecal matter (dry) with data presented in terms of absolute value 
Group Dry faecal matter in g/100 g body weight (absolute value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 4.29±0.23 3.79±0.14 -- 
Test drug 4.96±0.30 4.79±0.15*** 26.39↑ 
n=6, the expressions were calculated by taking mean±standard error to the mean ***p-value less than 0.001 was counted as extremely significant in 
comparison to control 
 
Table 9 shows after the administration of the test drug, dry faecal 
output in gm/d was a 26.39 % increase in the test group when 
compared to the control group. The increased data were statistically 
significant at the level of P<0.001. 
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Table 10: Effect of Bridelia stipularis (L.) blume on the faecal matter (dry) with data presented in terms of relative value 
Group Dry faecal matter in g/100 g body weight (relative value) 
Preliminary phase mean±sem Therapeutic phase mean±sem %Change 
Control 1.78±0.09 1.56±0.06 -- 
Test drug 2.04±0.13 1.88±0.12* 20.51↑ 
n=6, the expressions were calculated by taking mean±standard error to the mean, *p-value less than 0.05 was counted as significant in comparison 
to control  
 
Table 10 shows after the administration of the test drug, dry faecal 
output in gm/d was a 20.51 % increase in the test group compared 
to the control group. The increased data were statistically 
significant.
  
Table 11: Effect of Bridelia stipularis (L.) blume on faecal water with data presented in terms of absolute value 
Group Faecal water in ml/100 g body weight (absolute value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 4.23±0.16 4.29±0.24 -- 
Test drug 4.46±0.46 4.47±0.0.24 4.20↑ 
n=6, the expressions were calculated by taking mean±standard error to the mean p-value less than 0.05 was counted as significant in comparison to 
control 
 
Table 11 shows after the administration of the test drug, faecal 
water in ml/d was a 4.2% increase in the test group compared to 
the control group. The increased data were statistically non-
significant.
 
Table 12: Effect of Bridelia stipularis (L.) blume on faecal water with data presented in terms of relative value 
Group Faecal water in ml/100 g body weight (relative value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 1.66±0.06 1.74±0.08 -- 
Test drug 1.80±0.21 1.79±0.14 2.87↑ 
n=6, the expressions were calculated by taking mean±standard error to the mean p-value less than 0.05 was counted as significant in comparison to 
control 
 
Table 12 shows after administration of the test drug, faecal 
water in ml/d was a 2.87% increase in the test group compared 
to the control group. The increased data were statistically non-
significant. 
 
Table 13: Effect of Bridelia stipularis (L.) blume on food conversion ratio with data presented in terms of absolute value 
Group Food conversion ratio (absolute value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 4.28±0.36 4.29±0.18 -- 
Test drug 3.17±0.08 3.62±0.13* 15.62↓ 
n=6, the expressions were calculated by taking mean±standard error to the mean *p-value less than 0.05 was counted as significant in comparison 
to control 
 
Table 13 shows after the administration of the test drug, the 
food conversion ratio in absolute value was significantly 
(15.62% ↓) decreased  in the test group compared to the control 
group. 
  
Table 14: Effect of Bridelia stipularis (L.) blume on food conversion ratio with data presented in terms of relative value 
Group Food conversion ratio (relative value) 
Preliminary phase mean±sem Therapeutic phase mean±sem % Change 
Control 3.51±0.19 4.40±0.19  
Test drug 3.18±0.08 3.71±0.21** 15.68↓ 
n=6, the expressions were calculated by taking mean±standard error to the mean **p-value less than 0.01 was counted as highly significant in 
comparison to control 
 
Table 15: Effect of Bridelia stipularis (L.) blume on body weight 
Group Change in body weight (mean±sem) % change 
Control 1.34±1.13 -- 
Test drug 3.96±1.74 1.96↑ 
n=6, the expressions were calculated by taking mean±standard error to the mean p-value less than 0.05 was counted as significant in comparison to 
control. 
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Table 14 shows after the administration of the test drug, the food 
conversion ratio in relative value were significantly (15.68% ↓) 
decreased in the test group compared to the control group. 
Table 15 shows after the administration of the test drug, an increase 
in body weight were observed in the test group compared to the 
control group. However, the increased data were statistically not 
significant. 
DISCUSSION 
The quality or attributes obtained after the completion of the digestion 
of food or drug are known as vipaka. There is a difference in opinion 
about the number of vipākas. The most accepted one is Trividha 
Vipākavāda (three types of vipāka) which includes Madhura vipāka, 
Amla vipāka and Katu vipāka [6]. The effect of vipāka on the body is 
elaborately explained by Ācarya Caraka. He clearly explained the effect 
of each vipāka on dośa, dhātu, and mala. At dośa level, madhura vipaka 
is kapha vardhaka, amla vipāka is pitta vardhaka whereas kaṭu 
vipāka is vātā vardhaka in nature. At dhatu level, madhura vipāka may 
act as śukravardhaka and amla and kaṭu vipāka act as sukranaśana. In 
the formation of mala, madhura and amla vipāka causes 
sruṣṭavinmutrata whereas kaṭu vipāka results in badhaviṭmutrata [7]. 
During the experimental study, food intake, water intake, faecal wet, 
faecal dry, faecal water, and urine output were noted as increased. A 
significant increase in the faecal wet and dry matter along with an 
increase in faecal water shows the easy evacuation of faeces. This 
total effect may be considered as srisṭaviṇmūtrata (loose and easy 
evacuation of the bowel) which is the action of both Madhura 
vipāka and Amla vipāka. Madhura vipāka is guru and śukrala i. e 
Responsible for an increase in body weight and increased 
spermatogenesis. On the other hand; Amla vipāka is just the opposite 
of it, responsible for decreased spermatogenesis and body weight. In 
this study in the test drug group, the bodyweight of the rats also 
increased suggests the action of sweet metabolic transformation.  
On a preliminary analysis of rasa (Taste) and vīrya (active potency) as 
per available method (SC Dhyani; 2003), it was observed that leaves of 
the drug Bridelia stipularis have Kaṣāya pradhāna Tikta rasa (astringent 
and bitter taste) and śita vīrya (cold potency). This indicates that the 
leaves of the test drug may be a vicitrapratyayārabdha (an unusual 
combination of pancamahābhūtas). However, according to Parāśara 
Acharya, Kaṣāya  and Tikta rasa can be Madhura vipāka [8]. Hence it 
cannot be taken as vicitrapratyayarabdha (an unusual combination 
of pancamahābhūtas). Pittaghna property of the leaves of B. stiplaris also 
suggests the probability of Madhura Vipāka.
The increase in food intake noted as 4.76% and that of faecal dry 
matter was 20.51%. i.e. the percentage increase in food intake is less 
when compared with the faecal output. This shows that the drug has 
some 
  
dīpana effect and has no pācana 
CONCLUSION 
property. This is also clear 
from the status of food conversion ratio and change in body weight. 
Because bodyweight increased only by 2% and FCR (food 
conversion ratio) was decreased by 15% which means faecal output 
is greater than food consumption. 
It is high time to explore the ayurvedic pharmacological properties 
of extra-pharmacopoeial drugs using available methods which will 
lend a hand to fend off the problems faced by the Ayurveda 
community. Based on the preliminary assessment it may be 
concluded that the drug Bridelia stipularis (L.) Blume 
possess Madhura vipaka
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